Importantly, both HSP and NOS expression, the availability of free NO molecules and the interaction of HSP, NOS and antioxidant enzymes may play important roles in endothelial pathophysiology and the treatment of DCS or other diseases with endothelial dysfunction. This evidence concerns the gene NOS2 and Dorfman-Chanarin disease.